Algiecel, a Danish microalgae ingredients company developing reliable alternatives to fish-dependent supply chains, has strengthened its senior leadership team with the appointment of Mette Ingeman Pedersen as chief financial officer (CFO) and Tove Feld to chair its board of directors.
The appointments strengthen a female-led leadership team headed by CEO Susanne Palsten Buchardt and support Algiecel’s next phase of growth, building the financial, operational and governance capabilities needed to scale its controlled marine bioactives platform for nutrition, pet food and personal care markets.
Pedersen joins Algiecel after more than 20 years in senior finance, advisory and commercial roles across the Nordic region, with a focus on helping science-based and purpose-driven companies turn innovation into scalable business models. She previously served as CFO of Topsoe’s Power-to-X business, where she helped build the finance function and operating model for a rapidly scaling organization, supporting the commercial deployment of green technologies and first-of-a-kind industrial infrastructure.
Her experience also includes senior finance leadership roles at Saxo Bank, Nordea and Danske Bank, spanning finance transformation, IPO readiness, valuation modeling and fundraising preparation. At Algiecel, Pedersen will lead the finance function as the company prepares for commercial expansion and future investment.
“Algiecel is entering a decisive stage, where strong financial discipline must support ambitious commercial execution,” Pedersen said. “The company has developed a platform with the potential to make high-performing microalgae ingredients more reliable, scalable and commercially accessible. My focus will be on helping Algiecel build the structure, investor confidence and financial resilience needed for long-term growth.”
At the same time, Feld will chair Algiecel’s board of directors with 35 years of experience in energy, infrastructure, renewables and strategic transformation, including more than 15 years of board experience across private and listed companies. An engineer by training, she has held senior leadership roles at Ørsted and its predecessor DONG Energy, including chief technology officer and head of engineering, and has also held senior leadership roles at Siemens Wind Power and DNV.
Her appointment brings additional expertise in scaling technology-based companies, internationalization, investment, risk management and governance. At Algiecel, Feld will support the company as it moves from platform validation towards commercial production.
“Algiecel’s opportunity is not only about producing microalgae; it is about building a reliable industrial platform for marine bioactives,” Feld said. “The company combines biology, engineering and sustainability in a way that is highly relevant to the future of ingredient supply. I look forward to supporting the team as it moves towards commercial scale.”
“Scaling Algiecel requires more than promising technology,” said Susanne Palsten Buchardt, CEO of Algiecel. “It requires operational discipline, financial rigour, industrial experience and a leadership team capable of turning innovation into reliable commercial supply. Mette and Tove bring exactly that. Their appointments strengthen our ability to execute as we build Algiecel into a trusted supplier of effective microalgae ingredients delivered at scale.”
With Buchardt as CEO and Pedersen joining as CFO, women are represented across Algiecel’s central executive and board-level roles, including head of legal and HR, Rikke Dybvad, board member Merete Lundbye Møller and Feld’s appointment to the board.
Algiecel’s compact, modular bioreactors cultivate Nannochloropsis oceanica microalgae using artificial light, water and captured CO₂. The model is designed to provide predictable supply, consistent product quality and lower-risk, flexible scaling, helping customers reduce exposure to marine ingredient supply volatility.
